Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-07T14:21:27.371Z Has data issue: false hasContentIssue false

Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae

Published online by Cambridge University Press:  06 May 2009

H. AZIZI
Affiliation:
Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran
K. HASSANI
Affiliation:
Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran Department of Biotechnology, University College of Science, University of Tehran, Tehran, Iran
Y. TASLIMI
Affiliation:
Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran
H. SHATERI NAJAFABADI
Affiliation:
Institute of Parasitology, McGill University, Montreal, Canada
B. PAPADOPOULOU
Affiliation:
Research Centre in Infectious Diseases, CHUL Research Centre and Department of Medical Biology, Faculty of Medicine, Laval University, 2705 Laurier Blvd., Quebec (QC), Canada G1V 4G2
S. RAFATI*
Affiliation:
Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran
*
*Corresponding author: Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran. Tel: +98 21 66953311. Fax: +98 21 66465132. E-mail: s_rafati@yahoo.com or sima-rafatisy@pasteur.ac.ir
Rights & Permissions [Opens in a new window]

Summary

Leishmania protozoa are obligate intracellular parasites that reside in the phagolysosome of host macrophages and cause a large spectrum of pathologies to humans known as leishmaniases. The outcome of the disease is highly dependent on the parasite species and on its ascribed virulence factors and the immune status of the host. Characterization of the genome composition of non-pathogenic species could ultimately open new horizons in Leishmania developmental biology and also the disease monitoring. Here, we provide evidence that the lizard non-pathogenic to humans Leishmania tarentolae species expresses an Amastin-like gene, cysteine protease B (CPB), lipophosphoglycan LPG3 and the leishmanolysin GP63, genes well-known for their potential role in the parasite virulence. These genes were expressed at levels comparable to those in L. major and L. infantum both at the level of mRNA and protein. Alignment of the L. tarentolae proteins with their counterparts in the pathogenic species demonstrated that the degree of similarity varied from 59% and 60% for Amastin, 89% for LPG3 and 71% and 68% for CPB, in L. major and L. infantum, respectively. Interestingly, the A2 gene, expressed specifically by the L. donovani complex which promotes visceralization, was absent in L. tarentolae. These findings suggest that the lack of pathogenicity in L. tarentolae is not associated with known virulence genes such as LPG3, CPB, GP63 and Amastin, and that other factors either unique to L. tarentolae or missing from this species may be responsible for the non-pathogenic potential of this lizard parasite.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 2009
Figure 0

Fig. 1. Southern blot analyses of various virulence factors in the human-pathogenic Leishmania major (LM) and L. infantum (LI) and the non-pathogenic L. tarentolae (LT) species. With the exception of the amastigote-specific gene A2, the rest of the virulence genes tested are present in the genome of L. tarentolae and show similar digestion patterns, which suggests a similar copy number and genomic organization.

Figure 1

Fig. 2. Heat maps illustrating similarity of (A) LPG3, (B) amastin and (C) CPB among different Leishmania species. Each square represents one pairwise alignment; brighter colours represent higher similarity (white for 100%). Black represents 65·4% similarity, which is the lowest value observed in all alignments (L. tarentolae amastin vs L. braziliensis amastin). Heat maps were generated using Mayday (Dietzsch et al.2006).

Figure 2

Fig. 3. Expression ratios of Amastin, LPG3 and CPB genes in Leishmania tarentolae, L. major and L. infantum amastigotes and stationary phase promastigotes. Based on these results, LPG3 shows a slight increase in expression in amastigotes of L. major (amastigotes/promastigotes 1·65) and L. infantum (amastigotes/promastigotes, 1·86) compared to stationary phase promastigotes; whereas, in L. tarentolae expression of LPG3 seems to be constitutive (amastigotes/promastigotes, 0·93). CPB, similarly to all studied species shows a small increase in its expression in amastigote forms (1·23, 1·35 and 1·17 for amastigotes/promatigotes of L. major, L. infantum and L. tarentolae, respectively). Lastly, amastin (dark bars) is down regulated in L. major (amastigotes/promastigotes, 0·57) and L. tarentolae amastigotes (amastigotes/promastigotes, 0·56), while L. infantum shows a slight increase in amastigotes (amastigotes/promastigotes, 1·36). Standard deviation form CT is shown as error bars.

Figure 3

Table 1. CT values from two developmental stages of the three Leishmania species are shown(According to these results, expression levels of the studied genes in L. tarentolae are comparable to those of the other pathogenic species.)

Figure 4

Fig. 4. SDS-PAGE and Western blot analysis of LPG3, CPB and amastin proteins in Leishmania tarentolae, L. infantum and L. major. (A) Lysates of L. tarentolae (lane 2), L. infantum (Lane 3), L. major (lane 4), rLPG3 (Lane 5), rCPB (Lane 6) and amastin signature (Lane 7) were subjected to electrophoresis on 12·5% SDS-PAGE and stained with Coomasie blue. (B) Same samples were transferred to a nitrocellulose membrane and incubated with different polyclonal antibodies including anti-LPG3 (B1), anti-CPB (B2) and anti-amastin (B3) as described in the Materials and Methods section.

Supplementary material: PDF

Azizi Fig. S1A.pdf

Azizi Fig. S1A.pdf

Download Azizi Fig. S1A.pdf(PDF)
PDF 286.8 KB
Supplementary material: PDF

Azizi Fig. S1B.pdf

Azizi Fig. S1B.pdf

Download Azizi Fig. S1B.pdf(PDF)
PDF 6.1 KB
Supplementary material: PDF

Azizi Fig. S1C.pdf

Azizi Fig. S1C.pdf

Download Azizi Fig. S1C.pdf(PDF)
PDF 12.8 KB
Supplementary material: PDF

Azizi Fig. S1D.pdf

Azizi Fig. S1D.pdf

Download Azizi Fig. S1D.pdf(PDF)
PDF 18.7 KB